Literature DB >> 24696605

Inflammatory bowel disease course in Crohn's disease: is the natural history changing?

Petra A Golovics1, Michael D Mandel1, Barbara D Lovasz1, Peter L Lakatos1.   

Abstract

Crohn's disease (CD) is a multifactorial potentially debilitating disease. It has a variable disease course, but the majority of patients eventually develop penetrating or stricturing complications leading to repeated surgeries and disability. Studies on the natural history of CD provide invaluable data on its course and clinical predictors, and may help to identify patient subsets based on clinical phenotype. Most data are available from referral centers, however these outcomes may be different from those in population-based cohorts. New data suggest the possibility of a change in the natural history in Crohn's disease, with an increasing percentage of patients diagnosed with inflammatory disease behavior. Hospitalization rates remain high, while surgery rates seem to have decreased in the last decade. In addition, mortality rates still exceed that of the general population. The impact of changes in treatment strategy, including increased, earlier use of immunosuppressives, biological therapy, and patient monitoring on the natural history of the disease are still conflictive. In this review article, the authors summarize the available evidence on the natural history, current trends, and predictive factors for evaluating the disease course of CD.

Entities:  

Keywords:  Crohn’s disease; Disease course; Inflammatory bowel disease; Mortality; Natural history; Surgery

Mesh:

Substances:

Year:  2014        PMID: 24696605      PMCID: PMC3964392          DOI: 10.3748/wjg.v20.i12.3198

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  65 in total

Review 1.  Natural history of pediatric-onset inflammatory bowel disease: a systematic review.

Authors:  Bincy P Abraham; Seema Mehta; Hashem B El-Serag
Journal:  J Clin Gastroenterol       Date:  2012-08       Impact factor: 3.062

Review 2.  Recommendations for identifying Crohn's disease patients with poor prognosis.

Authors:  Pal Miheller; Lajos S Kiss; Mark Juhasz; Michael Mandel; Peter L Lakatos
Journal:  Expert Rev Clin Immunol       Date:  2013-01       Impact factor: 4.473

3.  Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis.

Authors:  Axel Dignass; Rami Eliakim; Fernando Magro; Christian Maaser; Yehuda Chowers; Karel Geboes; Gerassimos Mantzaris; Walter Reinisch; Jean-Frederic Colombel; Severine Vermeire; Simon Travis; James O Lindsay; Gert Van Assche
Journal:  J Crohns Colitis       Date:  2012-10-03       Impact factor: 9.071

4.  Patients enrolled in randomized controlled trials do not represent the inflammatory bowel disease patient population.

Authors:  Christina Ha; Thomas A Ullman; Corey A Siegel; Asher Kornbluth
Journal:  Clin Gastroenterol Hepatol       Date:  2012-02-15       Impact factor: 11.382

5.  Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010.

Authors:  Tine Jess; Morten Frisch; Jacob Simonsen
Journal:  Clin Gastroenterol Hepatol       Date:  2012-09-27       Impact factor: 11.382

6.  Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland.

Authors:  Pia Manninen; Anna-Liisa Karvonen; Heini Huhtala; Martin Rasmussen; Maarit Salo; Leena Mustaniemi; Ismo Pirttiniemi; Pekka Collin
Journal:  J Crohns Colitis       Date:  2011-11-16       Impact factor: 9.071

7.  Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort.

Authors:  Barbara Dorottya Lovasz; Laszlo Lakatos; Agnes Horvath; Istvan Szita; Tunde Pandur; Michael Mandel; Zsuzsanna Vegh; Petra Anna Golovics; Gabor Mester; Mihaly Balogh; Csaba Molnar; Erzsebet Komaromi; Lajos Sandor Kiss; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

8.  Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD).

Authors:  Corinne Gower-Rousseau; Francis Vasseur; Mathurin Fumery; Guillaume Savoye; Julia Salleron; Luc Dauchet; Dominique Turck; Antoine Cortot; Laurent Peyrin-Biroulet; Jean Frédéric Colombel
Journal:  Dig Liver Dis       Date:  2012-10-27       Impact factor: 4.088

Review 9.  The burden of inflammatory bowel disease in Europe.

Authors:  Johan Burisch; Tine Jess; Matteo Martinato; Peter L Lakatos
Journal:  J Crohns Colitis       Date:  2013-02-08       Impact factor: 9.071

10.  Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry.

Authors:  Charlotte I de Bie; Anders Paerregaard; Sanja Kolacek; Frank M Ruemmele; Sibylle Koletzko; John M E Fell; Johanna C Escher
Journal:  Inflamm Bowel Dis       Date:  2013-02       Impact factor: 5.325

View more
  7 in total

1.  Indian Society of Gastroenterology consensus statements on Crohn's disease in India.

Authors:  Balakrishnan S Ramakrishna; Govind K Makharia; Vineet Ahuja; Uday C Ghoshal; Venkataraman Jayanthi; Benjamin Perakath; Philip Abraham; Deepak K Bhasin; Shobna J Bhatia; Gourdas Choudhuri; Sunil Dadhich; Devendra Desai; Bhaba Dev Goswami; Sanjeev K Issar; Ajay K Jain; Rakesh Kochhar; Goundappa Loganathan; Sri Prakash Misra; C Ganesh Pai; Sujoy Pal; Mathew Philip; Anna Pulimood; Amarender S Puri; Gautam Ray; Shivaram P Singh; Ajit Sood; Venkatraman Subramanian
Journal:  Indian J Gastroenterol       Date:  2015-03-14

2.  Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012.

Authors:  Petra A Golovics; Laszlo Lakatos; Michael D Mandel; Barbara D Lovasz; Zsuzsanna Vegh; Zsuzsanna Kurti; Istvan Szita; Lajos S Kiss; Tunde Pandur; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

Review 3.  The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease.

Authors:  Christopher A Lamb; Aamir Saifuddin; Nick Powell; Florian Rieder
Journal:  Gastroenterology       Date:  2022-01-04       Impact factor: 22.682

Review 4.  A review of the therapeutic management of Crohn's disease.

Authors:  Aditi Kumar; Alexander Cole; Jonathan Segal; Philip Smith; Jimmy K Limdi
Journal:  Therap Adv Gastroenterol       Date:  2022-02-17       Impact factor: 4.409

5.  A multicenter, prospective, observational study of the long-term outcomes of Crohn's disease patients under routine care management in Greece.

Authors:  Spyridon Michopoulos; Gregorios Paspatis; Konstantinos Triantafyllou; Spyridon Potamianos; Vassiliki Nikolopoulou; Evangelos Akriviadis; John A Karagiannis; Spyridon Ladas; Maria Tampaki; Charalambos Tzathas
Journal:  Ann Gastroenterol       Date:  2018-07-20

Review 6.  Role of the IL23/IL17 Pathway in Crohn's Disease.

Authors:  Heike Schmitt; Markus F Neurath; Raja Atreya
Journal:  Front Immunol       Date:  2021-03-30       Impact factor: 7.561

Review 7.  Long-term Disease Course of Crohn's Disease: Changes in Disease Location, Phenotype, Activities, and Predictive Factors.

Authors:  Choong Wui Cho; Myung-Won You; Chi Hyuk Oh; Chang Kyun Lee; Sung Kyoung Moon
Journal:  Gut Liver       Date:  2022-03-15       Impact factor: 4.519

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.